Netflix, Tesla, IBM fall premarket; Johnson & Johnson, DR Horton rise By

-- U.S. traded in a mixed fashion Thursday,Forex trading platform with good reputation as investors digested a deluge of corporate earnings, with the tech sector in particular focus.

Here are some of the biggest premarket U.S. stock movers today:

• Netflix(NASDAQ:) stock fell 6.4% after the streaming giant’s quarterly and forecast fell short of estimates, even after it reported nearly 6 million subscriber additions.

• Tesla(NASDAQ:) stock fell 3.6% after CEO Elon Musk revealed plans to continue price cuts, squeezing future margins, which outweighed the EV manufacturer comfortably beating second-quarter profit forecasts.

• (NYSE:) stock fell 0.9% after the tech giant’s second-quarter fell short of expectations, bogged down by a decline in sales of its mainframe computers as businesses cut tech spending.

• Johnson & Johnson(NYSE:) stock rose 1.4% after the pharmaceutical company beat second-quarter expectations and lifted its 2023 profit forecast as it builds out its drug and medical devices pipeline.

• AB InBevADRs(NYSE:) rose 0.6% after Morgan Stanley upgraded its stance on the brewer to ‘overweight’ from ‘neutral’, saying it is now attractively valued after the Bud Light controversy.

• Taiwan Semiconductor Manufacturing(NYSE:) stock fell 3.5% after the Taiwanese chipmaker forecast a drop of around 10% in 2023 sales and flagged investment spending at the low end of estimates.

• American Airlines(NASDAQ:) stock fell 1.3% despite the carrier raising its annual forecast for adjusted profit despite fears of a looming economic slowdown.

• Philip Morris(NYSE:) stock rose 0.1% after the tobacco giant impressed with its quarterly profit, boosted by a let-up in soaring tobacco and labor costs and buoyant demand for its Zyn and IQOS products.

• Blackstone(NYSE:) stock fell 3.2% after the asset manager said its second-quarter distributable earnings slumped nearly 40%, owing to a sharp drop in asset sales.

• DR Horton(NYSE:) stock rose 3.8% after the home builder raised its forecast for full-year revenue, benefiting from strong demand and easing shortages of labor and construction supplies.

• (NYSE:) stock rose 0.7% after the medical devices manufacturer beat expectations for second-quarter profit, due to recovery in surgical procedure volumes and demand for its diabetes care devices.

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!